Glooko Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Glooko Inc. - overview
Established
2010
Location
Palo Alto, CA, US
Primary Industry
Healthcare IT
About
Glooko AB is a technology company based in the US that specializes in connected care solutions for diabetes management, providing healthcare providers with tools to monitor and analyze patient data effectively. Founded in 2010 by Yogen Dalal and headquartered in Palo Alto, US, Glooko Inc. focuses on delivering digital healthcare solutions for diabetes. The company has completed a total of 8 funding deals, with the most recent being a Series F funding round in October 2024, raising USD 100 mn led by Georgian, while also featuring contributions from Health Catalyst Capital Management and Canaan Partners.
Glooko has raised a total of USD 100 mn to date and currently holds a valuation of USD 420. 875 mn. Glooko specializes in connected care solutions for diabetes management, offering a comprehensive platform that includes remote patient monitoring, data integration, and analytics. Their core product enables healthcare providers to track and manage patients' glucose levels effectively, facilitating improved glycemic control through real-time data access.
Glooko's services are primarily targeted toward healthcare providers, including hospitals, diabetes care clinics, and health plans. The company’s products are currently available in several international markets, including the United States, Germany, Spain, and France. In 2022, Glooko reported a revenue of USD 7,908,974. 80 with an EBITDA of USD -4,448,153.
40. The company operates on a subscription-based revenue model, generating income through partnerships with healthcare providers and organizations that utilize their platform. In October 2024, Glooko Inc. raised USD 100 mn in Series F funding, which will be utilized to accelerate the global product expansion of its digital healthcare platform and enhance its life sciences initiatives for diabetes management.
The company plans to enter new geographic markets and regions in the coming years as part of its strategy to expand its reach.
Current Investors
Canaan Partners, Samsung Venture Investment, Social Capital
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Web Applications, Medical Software, Analytics & Performance Software
Website
www.glooko.com
Verticals
HealthTech, Mobile Apps
Total Amount Raised
Subscriber access only
Glooko Inc. - timeline of key events
Glooko Inc. - financials
| Fiscal Year Ended | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 | Dec 31, 2014 | Dec 31, 2015 | Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (USD) | 16,589,768 | 21,611,960 | - | 26,449,028 | 36,031,431 | 42,548,443 | 45,379,127 | 56,906,458 | 58,293,878 | - | - | - |
| % Revenue Growth (YoY) | - | 30.3% | (100.0%) | - | 36.2% | 18.1% | 6.7% | 25.4% | 2.4% | - | - | - |
| EBITDA (USD) | 1,614,945 | 3,755,164 | 2,798,315 | 2,375,408 | 7,638,454 | (9,069,234) | 3,245,271 | (1,220,199) | (12,220,873) | - | - | - |
| Operating Income (USD) | 772,341 | 3,077,867 | 2,070,375 | 1,514,052 | 6,541,540 | (10,160,064) | 2,107,890 | (2,501,233) | (14,136,590) | - | - | - |
| Operating Margin | 4.7% | 14.2% | - | 5.7% | 18.2% | (23.9%) | 4.6% | (4.4%) | (24.3%) | - | - | - |
| % EBITDA Margin | 9.7% | 17.4% | - | 9.0% | 21.2% | (21.3%) | 7.2% | (2.1%) | (21.0%) | - | - | - |
| NET Income (USD) | 750,615 | 3,086,931 | 2,038,210 | 1,183,901 | 5,074,077 | (4,789,747) | 1,565,204 | (1,620,045) | (20,185,918) | - | - | - |
| % Net Margin | 4.5% | 14.3% | - | 4.5% | 14.1% | (11.3%) | 3.4% | (2.8%) | (34.6%) | - | - | - |
Glooko Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Diasend AB | - |
Displaying 1 - 1 of 1
Glooko Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.